Slide 1: FY24 Unaudited Full Year Results Investor Presentation
ASX:VFX FY24 Unaudited Full Year Results Investor Presentation 29 August 2024 This announcement was approved for release by the Board of Directors FY24 RESULTS INVESTOR PRESENTATION / AUGUST 2024 / 1
Slide 2: Executive Summary
Executive Summary Need for Flagship customer sales In-demand Accelerating growth A clear pathway to Virtual Care & momentum product suite in ARR profitability • Progressive rise in chronic • WA PHA1 (Aged Care): • Early entry benefit across • $1.3m in ARR (30 June 2024)3 • FY24 Revenue of $6.95m5 up
Slide 3: The Visionflex mission
The Visionflex mission Empowering health practitioners globally with cutting edge technologies to elevate patient outcomes. PRO PRIETARY PRO PRIETARY H ARD W ARE SO FTW ARE Clear pathway to profitability TH IRD PARTY H ARD W ARE Visionflex proprietary hardware and software connect a range of third-p
Slide 4: Visionflex Revenue Model
Visionflex Revenue Model Offering Core HARDWARE SOFTWARE Key Product / Services Revenue RECURRING REVENUE Streams UPFRONT / ONE-OFF $5k – $30k per unit depending on solution ~$5k per annum for annual software license margin 60-65% GP margin 90-95% GP margin GP Revenue Repeat Each new software licens
Slide 5: FY24 Highlights
FY24 Highlights FY24 RESULTS INVESTOR PRESENTATION / AUGUST 2024 / 55
Slide 6: Strategy Summary and Progress in FY24
Strategy Summary and Progress in FY24 • WA Primary Health Alliance: 180 residential aged care sites with software licenses. $2.3m of hardware revenue + $0.4m of ARR. • Northern Queensland Primary Health Network: Initial 33 residential aged care sites across Northern Queensland with a further 3 sites
Slide 7: FY24 Financial Summary
FY24 Financial Summary Note: Presented below is the Visionflex division (including corporate costs), key financial metrics which provides a better representation of the underlying business moving forward. For a detailed group statutory Profit and Loss (including businesses exited during the year), r
Slide 8: FY24 Financial Overview
FY24 Financial Overview FY24 RESULTS INVESTOR PRESENTATION / AUGUST 2024 / 88
Slide 9: Financial Dashboard
Financial Dashboard Subscription $6.95m Australia $6.95m Hardware $0.3m Overseas $0.3m Other Revenue Revenue (By Type) $6.0m (By Region) $2.6m $2.6m $6.6m $0.1m $0.3m $2.3m $2.3m $0.2m $0.7m FY23 FY24 FY23 FY24 $1.3m FY23 FY24 ($0.7m) ARR Underlying Growth EBITDA $0.3m ($3.2m) FY23 FY24 FY24 RESULTS
Slide 10: Profit & Loss
Profit & Loss Strong Visionflex revenue growth while tightly managing the cost base to drive near-term profitability Note: Presented below is the Visionflex division P&L (including corporate costs), which provides a better representation of the 1• Subscription recurring revenue of $0.7m, underlying
Slide 11: Balance Sheet
Balance Sheet Improved balance sheet provides operating flexibility to pursue growth opportunities; proforma net assets (post raise) of ~$(1.0m) 1 •1 $1.2m cash at bank with further $1.0m received post capital raise (net of debt 2 repayments and Offer costs). •2 Income tax refund (R&D tax receivable
Slide 12: Cash Flow Statement
Cash Flow Statement Significant improvement in operating cashflow (noting this also includes loss-making businesses now exited) 1• Receipts from customers ($9.8m) 1 exceeds group revenue ($8.1m) highlighting strong cash conversion; 2 o Expected that working capital will improve over time as subscrip
Slide 13: Market drivers and the Visionflex solution
Market drivers and the Visionflex solution FY24 RESULTS INVESTOR PRESENTATION / AUGUST 2024 / 1 13 3
Slide 14: Corporate history
Corporate history • Incorporation of Visionflex Pty Ltd (2014) • R&D and patents related to ISO 14971 Medical Device • Reinstatement to ASX and company renamed to Visionflex Group Limited Risk Management (2015-2016) • GEIS® camera launch (2016) • Accelerated growth of Visionflex • MyHealth1st (MH1)
Slide 15: Structural Problems Driving a Shift to Virtual Care
Structural Problems Driving a Shift to Virtual Care THE PROBLEM THE SOLUTION Globally, healthcare is experiencing: Adoption of virtual care enables health care providers to deliver: CONSTRAINED CAPACITIES SURGE IN EXPENDITURE MORE CONSULTATIONS INCREASED EFFICIENCY Increasing frequency and availabil
Slide 16: The Visionflex Solution
The Visionflex Solution Empowering health practitioners globally with cutting edge technologies to elevate patient outcomes. PRO PRIETARY PRO PRIETARY H ARD W ARE SO FTW ARE TH IRD PARTY H ARD W ARE Visionflex proprietary hardware and software connect a range of third-party medical devices to empowe
Slide 17: Hardware
Hardware Visionflex hardware enables health practitioners to virtually conduct medical examinations with confidence and serves as a foundational step for establishing long term software subscriptions. MEDICAL CART + PERIPHERALS + PERIPHERALS + SOFTWARE DEVICE + PERIPHERALS + SOFTWARE SOFTWARE Mobile
Slide 18: Proprietary Software (Virtual Care Platform)
Proprietary Software (Virtual Care Platform) A virtual healthcare platform allowing practitioners to virtually examine, diagnose, monitor, and treat patients. Perform collaborative, clinical, evidence-based consultations between clinicians A user-friendly video conferencing platform that delivers he
Slide 19: Customers and Market Positioning Progress
Customers and Market Positioning Progress FY24 RESULTS INVESTOR PRESENTATION / AUGUST 2024 / 1 19 9
Slide 20: Strong momentum in key industry verticals
Strong momentum in key industry verticals PRIMARY HEALTH NETWORKS AGED CARE RESOURCE SECTOR LOCAL HEALTH DISTRICTS INDIGENOUS HEALTH ORGANISATIONS CORRECTIONAL FACILITIES FY24 RESULTS INVESTOR PRESENTATION / AUGUST 2024 / 20
Slide 21: Recent client wins in key industry verticals
Recent client wins in key industry verticals Flagship customers highlighting ‘land and expand’ opportunity. CLIENT CONTRACT VALUE IMPACT OPPORTUNITY • 180 licences (sites) • $2.3m of upfront • Flagship contract highlight's ability to win large • Given referenceabilty with flagship WA PHN, ability to
Slide 22: Opportunities to expand in key industry verticals
Opportunities to expand in key industry verticals INDIGENOUS HEALTH AGED/HOME CARE RESOURCE SECTOR CORRECTIONAL FACILITIES • NACCHO is the national peak body • Residential Aged Care: There are 886 • Global operations in remote and • There are 116 custodial correctional representing 145 Aboriginal He
Slide 23: International expansion
International expansion AGENCY 2 PARTNERSHIPS Visionflex products have UK & Europe generated over $1m in revenue in the past from Americas, Europe and Asia. $0.3m of sales to customers in 6 AGENCY 1 overseas countries in FY2024. PARTNERSHIPS AGENCY 3 PARTNERSHIPS Americas Untapped growth opportuniti
Slide 24: Outlook
Outlook FY24 RESULTS INVESTOR PRESENTATION / AUGUST 2024 / 224 4
Slide 25: Summary – Next chapter in Visionflex Journey
Summary – Next chapter in Visionflex Journey 1 Clear strategic plan to deliver profitable growth: 2 Transitioning to recurring revenue via SaaS: • Visionflex sole business focus in FY25 and beyond with new management • Transitioning to SaaS pricing delivering growth in annual recurring revenue deliv
Slide 26: Appendix
Appendix FY24 RESULTS INVESTOR PRESENTATION / AUGUST 2024 / 226 6
Slide 27: Board and Executive Management Team
Board and Executive Management Team EXECUTIVE LEADERSHIP TEAM Joshua Mundey Michael Kafrouni James Aulsebrook CHIEF EXECUTIVE OFFICER CHIEF OPERATING OFFICER CHIEF FINANCIAL OFFICER • Former Co-Founder & Chief Growth Officer at • 15+ years’ experience as a senior executive for multinational • CA wit
Slide 28: Capital structure
Capital structure COMPANY PROFILE AS AT 22 AUGUST 2024* VISIONFLEX GROUP (VFX) STOCK CHART Shares on Issue 2,917,824,527 (August 2023 to August 2024)** $0.014 5.0m Share Price $0.004 Volume Share Price Share Price ($) Volume Market capitalisation $11.7m $0.012 Options on Issue (unlisted, various ex
Slide 29: Important notices
Important notices This FY24 Results Investor Presentation (Presentation) has been prepared by Visionflex Group Limited ACN 138 897 533 (ASX:VFX) (Company) & is rounding. Accordingly, the actual calculations of these figures may differ from the figures set out in this Presentation. dated 29 August 20
Slide 30: Visionflex Group Limited
Visionflex Group Limited Unit 1, 8 Prosperity Parade, Warriewood NSW 2102 VISIONFLEX.COM.AU Joshua Mundey CHIEF EXECUTIVE OFFICER E: jmundey@visionflex.com FY24 RESULTS INVESTOR PRESENTATION / AUGUST 2024 / 330 0